CD33 and neoplasm: The inferred MIF signaling network further revealed that tumor cells and CAFs are prominent sources of MIF ligands acting on MDSCs (CD33+CD11b+HLA-DRlo), monocytes or macrophages and DCs (Supplementary Fig. S6d).